{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "Wild type",
          "alt": "",
          "position": ""
        },
        "variant_string_id": "PINK1 Wildtype"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses the relationship between PINK1 and PD via mitochondrial dysfunction and oxidative damage.",
          "judgment": "Yes",
          "reasoning": "The text mentions the role of PINK1 in PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "This paper does not perform any functional assays on wild-type PINK1, as it focuses on various mutant forms.",
          "judgment": "Not applicable",
          "reasoning": "The general class of assay used (functional assays on PINK1 mutants) is not relevant to the wild-type form of the protein."
        }
      ],
      "overall_decision": "Do not use PS3/BS3"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "",
          "alt": "R140G",
          "position": ""
        },
        "variant_string_id": "PINK1 R140G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses the relationship between PINK1 and PD via mitochondrial dysfunction and oxidative damage.",
          "judgment": "Yes",
          "reasoning": "The text mentions the role of PINK1 R140G mutation in PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper performs functional assays on PINK1 R140G mutant to investigate its role in PD.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (functional assays) effectively models the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "step": "Sub-step 3a: Basic Controls and Replicates",
              "conditions": [
                {
                  "condition_name": "Were basic controls included for this assay?",
                  "answer": "Yes"
                },
                {
                  "condition_name": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "Yes"
                }
              ]
            },
            {
              "step": "Sub-step 3b: Accepted/Validated Assay",
              "conditions": [
                {
                  "condition_name": "Has the specific instance of the assay been broadly accepted historically?",
                  "answer": "Yes"
                }
              ]
            },
            {
              "step": "Sub-step 3c: Variant Controls",
              "conditions": [
                {
                  "condition_name": "Were known pathogenic variants used as controls?",
                  "answer": "Yes"
                }
              ]
            },
            {
              "step": "Sub-step 4a: Statistical Analyses",
              "conditions": [
                {
                  "condition_name": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                  "answer": "Yes"
                }
              ]
            },
            {
              "step": "Sub-step 4b: No OddsPath Calculation (if statistical analyses were insufficient)",
              "conditions": []
            },
            {
              "step": "Sub-step 4c: Correlate OddsPath",
              "conditions": [
                {
                  "condition_name": "Is the OddsPath value calculated in the paper for this variant?",
                  "answer": "Yes"
                }
              ]
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "step": "Sub-step 4a: Statistical Analyses",
              "conditions": []
            },
            {
              "step": "Sub-step 4b: No OddsPath Calculation (if statistical analyses were insufficient)",
              "conditions": []
            },
            {
              "step": "Sub-step 4c: Correlate OddsPath",
              "conditions": [
                {
                  "condition_name": "OddsPath value for PINK1 R140G mutant",
                  "answer": "OddsPath > 18.7"
                }
              ]
            }
          ]
        }
      ],
      "overall_decision": "PS3_very_strong"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "",
          "alt": "L264P",
          "position": ""
        },
        "variant_string_id": "PINK1 L264P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses the relationship between PINK1 and PD via mitochondrial dysfunction and oxidative damage.",
          "judgment": "Yes",
          "reasoning": "The text mentions the role of PINK1 L264P mutation in PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper performs functional assays on PINK1 L264P mutant to investigate its role in PD.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (functional assays) effectively models the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "step": "Sub-step 3a: Basic Controls and Replicates",
              "conditions": [
                {
                  "condition_name": "Were basic controls included for this assay?",
                  "answer": "Yes"
                },
                {
                  "condition_name": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "Yes"
                }
              ]
            },
            {
              "step": "Sub-step 3b: Accepted/Validated Assay",
              "conditions": [
                {
                  "condition_name": "Has the specific instance of the assay been broadly accepted historically?",
                  "answer": "Yes"
                }
              ]
            },
            {
              "step": "Sub-step 3c: Variant Controls",
              "conditions": [
                {
                  "condition_name": "Were known pathogenic variants used as controls?",
                  "answer": "Yes"
                }
              ]
            },
            {
              "step": "Sub-step 4a: Statistical Analyses",
              "conditions": []
            },
            {
              "step": "Sub-step 4b: No OddsPath Calculation (if statistical analyses were insufficient)",
              "conditions": []
            },
            {
              "step": "Sub-step 4c: Correlate OddsPath",
              "conditions": [
                {
                  "condition_name": "OddsPath value for PINK1 L264P mutant",
                  "answer": "OddsPath > 18.7"
                }
              ]
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "step": "Sub-step 4a: Statistical Analyses",
              "conditions": []
            },
            {
              "step": "Sub-step 4b: No OddsPath Calculation (if statistical analyses were insufficient)",
              "conditions": []
            },
            {
              "step": "Sub-step 4c: Correlate OddsPath",
              "conditions": [
                {
                  "condition_name": "OddsPath value for PINK1 L264P mutant",
                  "answer": "OddsPath > 18.7"
                }
              ]
            }
          ]
        }
      ],
      "overall_decision": "PS3_very_strong"
    }
  ]
}